• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Intuit, Workday And Other Big Stocks Moving Lower In Friday's Pre-Market Session

    5/24/24 5:45:52 AM ET
    $CGNT
    $GMAB
    $INTU
    $LAAC
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $CGNT alert in real time by email

    U.S. stock futures were higher this morning, with the Dow futures gaining around 50 points on Friday.

    Shares of Intuit Inc. (NASDAQ:INTU) fell sharply in today's pre-market trading following third-quarter results.

    Intuit posted better-than-expected earnings for its third quarter and boosted its full-year outlook. However, the company issued weak earnings guidance for the current quarter.

    Intuit's third-quarter revenue increased 12% year-over-year to $6.737 billion, beating the consensus estimate of $6.647 billion. The financial technology platform company reported adjusted earnings of $9.88 per share, beating analyst estimates of $9.37 per share, according to Benzinga Pro.

    Intuit shares declined 6.3% to $620.82 in pre-market trading.

    Here are some big stocks recording losses in today's pre-market trading session.

    • Summit Therapeutics Inc. (NASDAQ:SMMT) shares dipped 21.2% to $3.40 in pre-market trading.
    • Workday, Inc. (NASDAQ:WDAY) shares fell 12.4% to $228.48 in pre-market trading. Workday posted upbeat earnings for its first quarter. However, the company lowered its forward guidance and now sees second-quarter subscription revenue of $1.895 billion and fiscal-year subscription revenue of between $7.7 billion and $7.725 billion.
    • Cognyte Software Ltd. (NASDAQ:CGNT) shares declined 6.9% to $6.94 in pre-market trading.
    • Genmab A/S (NASDAQ:GMAB) shares fell 4.5% to $28.01 in pre-market trading.
    • NetEase, Inc. (NASDAQ:NTES) shares declined 3.7% to $91.15 in pre-market trading after the company reported worse-than-expected first-quarter revenue.
    • Lithium Americas (Argentina) Corp (NYSE:LAAC) shares fell 2.4% to $4.58 in pre-market trading.
    • Ryanair Holdings plc (NASDAQ:RYAAY) shares slipped 2.3% to $124.72 in pre-market trading.

    Now Read This: SLB, First Solar And 2 Other Stocks Insiders Are Selling

    Don't forget to check out our premarket coverage here

    Get the next $CGNT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CGNT
    $GMAB
    $INTU
    $LAAC

    CompanyDatePrice TargetRatingAnalyst
    Ryanair Holdings plc
    $RYAAY
    2/18/2026Buy → Hold
    Erste Group
    Workday Inc.
    $WDAY
    2/18/2026Mkt Outperform → Mkt Perform
    Citizens
    Genmab A/S
    $GMAB
    2/17/2026$41.50Buy
    Jefferies
    Genmab A/S
    $GMAB
    2/17/2026$34.00Equal-Weight
    Morgan Stanley
    Workday Inc.
    $WDAY
    2/17/2026$285.00 → $204.00Outperform
    BMO Capital Markets
    Intuit Inc.
    $INTU
    2/10/2026$810.00 → $624.00Outperform
    BMO Capital Markets
    Workday Inc.
    $WDAY
    1/12/2026$238.00Neutral
    Goldman
    Intuit Inc.
    $INTU
    1/12/2026$720.00Neutral
    Goldman
    More analyst ratings

    $CGNT
    $GMAB
    $INTU
    $LAAC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Intuit TurboTax Delivers the Ultimate "Done-For-You" Tax Experience Powered by AI and Human Intelligence With Uber Rides

    New campaign offers TurboTax filers free Uber rides, up to $25, to its 20 new stores and expert offices, ensuring the journey to their best tax outcome is as seamless as the tax prep Intuit Inc. (NASDAQ:INTU), the global financial technology platform that makes Intuit TurboTax, Credit Karma, QuickBooks, Mailchimp, and Intuit Enterprise Suite, today announced a strategic campaign with Uber Advertising to close the gap between taxpayers and trusted financial expertise. As part of the expansion of its Human Intelligence (HI) service network, including nearly 600 Expert Offices and 20 immersive stores, TurboTax is providing customers with a free* Uber ride, up to $25, to meet their local Turb

    2/19/26 7:00:00 AM ET
    $INTU
    Computer Software: Prepackaged Software
    Technology

    Fourlane Now an Official Reseller of Intuit Enterprise Suite, Expanding Decade-Long QuickBooks Leadership

    Fourlane, the nation's top-ranked Intuit QuickBooks Solution Provider, and Intuit Inc. (NASDAQ:INTU), the global financial technology platform that makes Intuit TurboTax, Credit Karma, QuickBooks, Mailchimp, and Intuit Enterprise Suite, today announced that Fourlane has been appointed an official reseller of Intuit Enterprise Suite, Intuit's cloud-based, AI-native ERP solution built to help complex mid-market organizations scale. The designation expands a relationship that began in 2010 and strengthens Fourlane's position as a leading QuickBooks and ERP advisory partner. As an official Intuit Enterprise Suite reseller, Fourlane will provide software licensing, implementation, data migrati

    2/18/26 10:00:00 AM ET
    $INTU
    Computer Software: Prepackaged Software
    Technology

    Summit Therapeutics to Host Fourth Quarter and Full Year 2025 Financial Results & Operational Progress Call on February 23, 2026

    Conference Call to be Held at 4:30pm ET Summit Therapeutics Inc. (NASDAQ:SMMT) ("Summit," "we," or the "Company") will host an earnings call to announce its fourth quarter and full year 2025 financial results and provide an operational update for the Company on Monday, February 23, 2026, after the market closes. Summit will host a live webcast of the earnings conference call at 4:30pm ET, which will be accessible through our website, www.smmttx.com. An archived edition of the session will be available on our website. About Summit Therapeutics Summit Therapeutics Inc. is a biopharmaceutical oncology company focused on the discovery, development, and commercialization of patient-, phy

    2/17/26 5:05:00 PM ET
    $SMMT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CGNT
    $GMAB
    $INTU
    $LAAC
    SEC Filings

    View All

    SEC Form 6-K filed by Genmab A/S

    6-K - GENMAB A/S (0001434265) (Filer)

    2/20/26 10:07:25 AM ET
    $GMAB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Ryanair Holdings plc

    6-K - RYANAIR HOLDINGS PLC (0001038683) (Filer)

    2/19/26 6:27:21 AM ET
    $RYAAY
    Air Freight/Delivery Services
    Consumer Discretionary

    SEC Form 6-K filed by Genmab A/S

    6-K - GENMAB A/S (0001434265) (Filer)

    2/18/26 10:07:15 AM ET
    $GMAB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CGNT
    $GMAB
    $INTU
    $LAAC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Ryanair Hldgs downgraded by Erste Group

    Erste Group downgraded Ryanair Hldgs from Buy to Hold

    2/18/26 9:43:08 AM ET
    $RYAAY
    Air Freight/Delivery Services
    Consumer Discretionary

    Workday downgraded by Citizens

    Citizens downgraded Workday from Mkt Outperform to Mkt Perform

    2/18/26 7:53:34 AM ET
    $WDAY
    EDP Services
    Technology

    Jefferies resumed coverage on Genmab with a new price target

    Jefferies resumed coverage of Genmab with a rating of Buy and set a new price target of $41.50

    2/17/26 8:18:22 AM ET
    $GMAB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CGNT
    $GMAB
    $INTU
    $LAAC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Eschenbach Carl M. covered exercise/tax liability with 1,674 shares, decreasing direct ownership by 0.27% to 622,969 units (SEC Form 4)

    4 - Workday, Inc. (0001327811) (Issuer)

    2/9/26 4:30:51 PM ET
    $WDAY
    EDP Services
    Technology

    SEC Form 4 filed by Director Yuan Eric S.

    4 - INTUIT INC. (0000896878) (Issuer)

    1/26/26 5:18:27 PM ET
    $INTU
    Computer Software: Prepackaged Software
    Technology

    Director Vazquez Raul converted options into 347 shares, increasing direct ownership by 33% to 1,406 units (SEC Form 4)

    4 - INTUIT INC. (0000896878) (Issuer)

    1/26/26 5:11:57 PM ET
    $INTU
    Computer Software: Prepackaged Software
    Technology

    $CGNT
    $GMAB
    $INTU
    $LAAC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Genmab A/S bought $102,411,048 worth of shares (1,055,784 units at $97.00) (SEC Form 4)

    4 - GENMAB A/S (0001434265) (Reporting)

    12/30/25 5:41:44 PM ET
    $GMAB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Xia Yu bought $9,999,983 worth of shares (533,617 units at $18.74) (SEC Form 4)

    4 - Summit Therapeutics Inc. (0001599298) (Issuer)

    10/23/25 9:06:30 PM ET
    $SMMT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Co-Chief Executive Officer Duggan Robert W bought $499,983 worth of shares (26,680 units at $18.74) and was granted 14,247,597 shares, increasing direct ownership by 3% to 570,073,879 units (SEC Form 4)

    4 - Summit Therapeutics Inc. (0001599298) (Issuer)

    10/23/25 4:08:30 PM ET
    $SMMT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CGNT
    $GMAB
    $INTU
    $LAAC
    Leadership Updates

    Live Leadership Updates

    View All

    Workday Announces CEO Transition as Co-Founder Aneel Bhusri Returns to Lead the Company's Next Chapter

    Carl Eschenbach Steps Down After Leading Company Through a Period of Global Expansion and Operational Scale Company Reaffirms Fiscal 2026 Fourth Quarter and Full-Year Outlook PLEASANTON, Calif., Feb. 9, 2026 /PRNewswire/ -- Workday, Inc. (NASDAQ:WDAY), the enterprise AI platform for managing people, money, and agents, today announced that co-founder and current executive chair Aneel Bhusri is returning as chief executive officer as the company enters its next chapter, focused on leading in the rapidly evolving AI era. Carl Eschenbach is stepping down as CEO and as a member of the board after leading Workday through a period defined by global growth, an expanded industry focus, and strengthen

    2/9/26 8:30:00 AM ET
    $WDAY
    EDP Services
    Technology

    Workiva Announces Two New Appointments to Board of Directors

    Company Appoints Former Cisco and Autodesk CFO Scott Herren and Former Workday Co-President, CFO, and EVP Mark Peek Workiva Inc. (NYSE:WK), a leading, AI-powered platform for trust, transparency, and accountability, today announced the appointment of two new independent directors to its Board of Directors. Scott Herren is the former EVP and Chief Financial Officer of Cisco and current Board member and Audit Committee Chair at Rubrik (NYSE:RBRK). Mark Peek is a former EVP, CFO, and Co-President of Workday (NASDAQ:WDAY) and currently sits on the Board of Directors for SentinelOne (NYSE:S) and Trimble (NASDAQ:TRMB). "We are pleased to welcome two highly experienced SaaS leaders to our Boar

    1/28/26 4:05:00 PM ET
    $RBRK
    $S
    $TRMB
    Computer Software: Prepackaged Software
    Technology
    Industrial Machinery/Components
    Industrials

    Workday to Invest CAD $1 Billion in Canada Over Five Years

    Investment to Fuel the Growth of Workday's Canadian Business and Support Workday's Rapidly Growing Canadian Customer Base Company Joins With Glowing Hearts Reservist Registry as Part of Ongoing Efforts to Support Local Communities in Canada PLEASANTON, Calif., Jan. 20, 2026 /PRNewswire/ -- Workday, Inc.  (NASDAQ:WDAY), the enterprise AI platform for managing people, money, and agents, today announced its plans to invest CAD $1 billion in Canada over the next five years. The multi-year investment demonstrates Workday's commitment to growing in Canada, including plans to further develop local tech talent, strengthen local customer support, and give back to Canadian communities through particip

    1/20/26 8:00:00 AM ET
    $WDAY
    EDP Services
    Technology

    $CGNT
    $GMAB
    $INTU
    $LAAC
    Financials

    Live finance-specific insights

    View All

    Summit Therapeutics to Host Fourth Quarter and Full Year 2025 Financial Results & Operational Progress Call on February 23, 2026

    Conference Call to be Held at 4:30pm ET Summit Therapeutics Inc. (NASDAQ:SMMT) ("Summit," "we," or the "Company") will host an earnings call to announce its fourth quarter and full year 2025 financial results and provide an operational update for the Company on Monday, February 23, 2026, after the market closes. Summit will host a live webcast of the earnings conference call at 4:30pm ET, which will be accessible through our website, www.smmttx.com. An archived edition of the session will be available on our website. About Summit Therapeutics Summit Therapeutics Inc. is a biopharmaceutical oncology company focused on the discovery, development, and commercialization of patient-, phy

    2/17/26 5:05:00 PM ET
    $SMMT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Genmab Publishes 2025 Annual Report

    Company Announcement COPENHAGEN, Denmark; February 17, 2026 – Genmab A/S (NASDAQ:GMAB) announced today the publication of its Annual Report for 2025. Below is a summary of business progress in 2025, financial performance for the year and the financial outlook for 2026. The full report is attached as a PDF file and in iXBRL format and can be found in the investor section of the company's website, www.genmab.com/investor-relations. Conference CallGenmab will hold a conference call to discuss the full year results for 2025 today, February 17, 2026 at 6:00 pm CET, 5:00 pm GMT, 12:00 pm EST. To join the call please use the below registration link. Registered participants will receive an email w

    2/17/26 11:01:23 AM ET
    $GMAB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    NetEase Cloud Music Inc. Reports Fiscal Year 2025 Financial Results

    HANGZHOU, China, Feb. 11, 2026 /PRNewswire/ -- NetEase Cloud Music Inc. (HKEX: 9899 or the "Company"), a leading interactive music streaming service provider in China, today announced its financial results for the fiscal year 2025 ended December 31, 2025. Summary of Key Financial Metrics (RMB in thousands, unless otherwise stated) Year ended 31 December 2025 2024 (Unaudited) (Unaudited) Revenue 7,759,450 7,950,146 Gross profit 2,769,592 2,681,512 Operating profit 1,621,952 1,170,847 Profit before income tax 2,067,738 1,570,255 Profit for the year (1) 2,745,828 1,565,369 Non-IFRS Measure (2): Adjusted operating profit 1,733,749 1,309,418 Adjusted net profit 2,860,007 1,700,078 Note: (1)  Du

    2/11/26 4:55:00 AM ET
    $NTES
    Computer Software: Prepackaged Software
    Technology

    $CGNT
    $GMAB
    $INTU
    $LAAC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Cognyte Software Ltd.

    SC 13G/A - Cognyte Software Ltd. (0001824814) (Subject)

    11/12/24 4:07:25 PM ET
    $CGNT
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Cognyte Software Ltd.

    SC 13G/A - Cognyte Software Ltd. (0001824814) (Subject)

    10/7/24 8:01:25 AM ET
    $CGNT
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Ryanair Holdings plc

    SC 13G/A - RYANAIR HOLDINGS PLC (0001038683) (Subject)

    10/1/24 1:46:37 PM ET
    $RYAAY
    Air Freight/Delivery Services
    Consumer Discretionary